ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-06-15 · last update 2026-06-15

Manufacturers: Amneal Pharmaceuticals

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)Amneal PharmaceuticalsTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 06/15/2026
Updated 06/15/2026
Discontinued 06/15/2026
Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)Amneal PharmaceuticalsTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 06/15/2026
Updated 06/15/2026
Discontinued 06/15/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)